These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Commentary: pediatric antifungal drug development: lessons learned and recommendations for the future. Watt KM; Cohen-Wolkowiez M; Ward RM; Benjamin DK Pediatr Infect Dis J; 2012 Jun; 31(6):635-7. PubMed ID: 22414903 [No Abstract] [Full Text] [Related]
5. Safety and pharmacokinetic profiles of repeated-dose micafungin in children and adolescents treated for invasive candidiasis. Benjamin DK; Deville JG; Azie N; Kovanda L; Roy M; Wu C; Arrieta A Pediatr Infect Dis J; 2013 Nov; 32(11):e419-25. PubMed ID: 23958810 [TBL] [Abstract][Full Text] [Related]
7. Echinocandin use in the neonatal intensive care unit. Caudle KE; Inger AG; Butler DR; Rogers PD Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252 [TBL] [Abstract][Full Text] [Related]
8. Micafungin use in children. Emiroglu M Expert Rev Anti Infect Ther; 2011 Sep; 9(9):821-34. PubMed ID: 21905789 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of prophylactic micafungin in very-low-birth-weight infants. Kawada M; Fukuoka N; Kondo M; Okazaki K; Kusaka T; Kawada K; Itoh S Pediatr Infect Dis J; 2009 Sep; 28(9):840-2. PubMed ID: 19636279 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of micafungin and its metabolites M1 and M5 in children and adolescents. Hope WW; Kaibara A; Roy M; Arrieta A; Azie N; Kovanda LL; Benjamin DK Antimicrob Agents Chemother; 2015 Feb; 59(2):905-13. PubMed ID: 25421470 [TBL] [Abstract][Full Text] [Related]
12. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial. Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A; Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151 [TBL] [Abstract][Full Text] [Related]
13. Safety of micafungin in infants: insights into optimal dosing. Ascher S; Smith PB; Benjamin DK Expert Opin Drug Saf; 2011 Mar; 10(2):281-6. PubMed ID: 21226655 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Smith PB; Walsh TJ; Hope W; Arrieta A; Takada A; Kovanda LL; Kearns GL; Kaufman D; Sawamoto T; Buell DN; Benjamin DK Pediatr Infect Dis J; 2009 May; 28(5):412-5. PubMed ID: 19319022 [TBL] [Abstract][Full Text] [Related]
16. Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Carter NJ; Keating GM Paediatr Drugs; 2009; 11(4):271-91. PubMed ID: 19566111 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and safety profiles of repeated-dose prophylactic micafungin in children and adolescents undergoing hematopoietic stem cell transplantation. Albano E; Azie N; Roy M; Townsend R; Arrieta A J Pediatr Hematol Oncol; 2015 Jan; 37(1):e45-50. PubMed ID: 25072363 [TBL] [Abstract][Full Text] [Related]
18. [Why might micafungin be the drug of choice in pediatric patients?]. Ramos Amador JT; Prieto Tato L; Guillén Martín S Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 2():23-8. PubMed ID: 21420573 [TBL] [Abstract][Full Text] [Related]
19. Use of pharmacokinetic-pharmacodynamic analyses to optimize therapy with the systemic antifungal micafungin for invasive candidiasis or candidemia. Andes D; Ambrose PG; Hammel JP; Van Wart SA; Iyer V; Reynolds DK; Buell DN; Kovanda LL; Bhavnani SM Antimicrob Agents Chemother; 2011 May; 55(5):2113-21. PubMed ID: 21300835 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of micafungin in HIV positive patients with confirmed esophageal candidiasis. Undre N; Stevenson P; Baraldi E Eur J Drug Metab Pharmacokinet; 2012 Mar; 37(1):31-8. PubMed ID: 21956255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]